Similar articles for PMID: 35093883

Year	Number of Results
2005	3
2006	2
2008	1
2009	1
2011	7
2012	5
2013	1
2014	4
2015	11
2016	7
2017	9
2018	16
2019	15
2020	12
2021	14
2022	15

1

Inhibitory Effect of Oxaliplatin-loaded Engineered Milk Extracellular Vesicles on Tumor Progression.

Go G, Park HJ, Lee JH, Yun CW, Lee SH. Go G, et al. Anticancer Res. 2022 Feb;42(2):857-866. doi: 10.21873/anticanres.15543. Anticancer Res. 2022. PMID: 35093883

2

GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.

Pi J, Jiang J, Cai H, Yang F, Jin H, Yang P, Cai J, Chen ZW. Pi J, et al. Drug Deliv. 2017 Nov;24(1):1549-1564. doi: 10.1080/10717544.2017.1386729. Drug Deliv. 2017. PMID: 29019267 Free PMC article.

3

GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation.

Cheng L, Huang FZ, Cheng LF, Zhu YQ, Hu Q, Li L, Wei L, Chen DW. Cheng L, et al. Int J Nanomedicine. 2014 Feb 12;9:921-35. doi: 10.2147/IJN.S53310. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24611009 Free PMC article.

4

Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.

Brinkman AM, Chen G, Wang Y, Hedman CJ, Sherer NM, Havighurst TC, Gong S, Xu W. Brinkman AM, et al. Biomaterials. 2016 Sep;101:20-31. doi: 10.1016/j.biomaterials.2016.05.041. Epub 2016 May 27. Biomaterials. 2016. PMID: 27267625 Free PMC article.

5

GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers.

Xu WW, Liu DY, Cao YC, Wang XY. Xu WW, et al. Int J Nanomedicine. 2017 Sep 5;12:6461-6470. doi: 10.2147/IJN.S129946. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28919747 Free PMC article.

6

PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors.

Abourbeh G, Shir A, Mishani E, Ogris M, Rödl W, Wagner E, Levitzki A. Abourbeh G, et al. IUBMB Life. 2012 Apr;64(4):324-30. doi: 10.1002/iub.1002. Epub 2012 Feb 23. IUBMB Life. 2012. PMID: 22362419 Free PMC article.

7

Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery.

Pham TC, Jayasinghe MK, Pham TT, Yang Y, Wei L, Usman WM, Chen H, Pirisinu M, Gong J, Kim S, Peng B, Wang W, Chan C, Ma V, Nguyen NTH, Kappei D, Nguyen XH, Cho WC, Shi J, Le MTN. Pham TC, et al. J Extracell Vesicles. 2021 Feb;10(4):e12057. doi: 10.1002/jev2.12057. Epub 2021 Feb 16. J Extracell Vesicles. 2021. PMID: 33643546 Free PMC article.

8

Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer.

Li C , Cai G , Song D , Gao R , Teng P , Zhou L , Ji Q , Sui H , Cai J , Li Q , Wang Y . Li C , et al. Biomater Sci. 2019 Aug 20;7(9):3627-3639. doi: 10.1039/c9bm00613c. Biomater Sci. 2019. PMID: 31328737

9

EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.

Fang Y, Yang W, Cheng L, Meng F, Zhang J, Zhong Z. Fang Y, et al. Acta Biomater. 2017 Dec;64:323-333. doi: 10.1016/j.actbio.2017.10.013. Epub 2017 Oct 10. Acta Biomater. 2017. PMID: 29030307

10

Synthesis and Analysis of ⁶⁴Cu-Labeled GE11-Modified Polymeric Micellar Nanoparticles for EGFR-Targeted Molecular Imaging in a Colorectal Cancer Model.

Paiva I, Mattingly S, Wuest M, Leier S, Vakili MR, Weinfeld M, Lavasanifar A, Wuest F. Paiva I, et al. Mol Pharm. 2020 May 4;17(5):1470-1481. doi: 10.1021/acs.molpharmaceut.9b01043. Epub 2020 Apr 9. Mol Pharm. 2020. PMID: 32233491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed